Following up the findings of Tantisira et al. in asthma12, Van den Berge and colleagues firstly investigated the role of GLCCI1 rs37972 polymorphism in ICS therapeutic response in 63 Dutch COPD patients. This evidence concerns the gene GLCCI1 and chronic obstructive pulmonary disease.